Showing results (1751-1760 of 4,265) with videos related to
Sort By:
Pageof 427
Cancer Discovery|July 27, 2013
PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapyJing Tan, Zhimei Li, Puay Leng Lee, et al.Cancer Discovery|August 10, 2014
DNA-damage response during mitosis induces whole-chromosome missegregationSamuel F Bakhoum, Lilian Kabeche, John P Murnane, et al.Cancer Discovery|January 16, 2013
Unpicking the combination lock for mutant BRAF and RAS melanomasBissan Al-Lazikani, Paul WorkmanCancer Discovery|January 16, 2013
Mechanisms of resistance to PARP inhibitors--three and countingTito Fojo, Susan BatesCancer Discovery|December 12, 2012
MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironmentJonathan Chou, Zena WerbCancer Discovery|December 12, 2012
Integrative cancer epidemiology--the next generationMargaret R Spitz, Neil E Caporaso, Thomas A SellersCancer Discovery|December 12, 2012
Compendia goes clinicalCancer Discovery|December 12, 2012
Whole-genome analysis personalizes breast cancer treatmentCancer Discovery|December 18, 2012
The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescenceMeaghan Wall, Gretchen Poortinga, Kym L Stanley, et al.Cancer Discovery|May 16, 2012
A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastomaAnita C Bellail, Jeffrey J Olson, Xiaolu Yang, et al.Pageof 427